Month: August 2023

Aug 03 2023

Uncategorized

New neuroimaging approach could improve diagnosis of schizophrenia

by Clinical Editor

No Comments

New research has identified age-related changes in brain patterns associated with the risk for developing schizophrenia. The discovery could help clinicians identify the risk for developing mental …

Aug 03 2023

Uncategorized

Researchers develop new way to detect brain changes associated with schizophrenia

by Clinical Editor

No Comments

New research led by scientists working with Georgia State University’s TReNDS Center has identified age-related changes in brain patterns associated with the risk for developing schizophrenia.

Aug 03 2023

Uncategorized

Sumitomo Schizophrenia Drug Discovered With AI Tech Fails in Two Phase 3 Trials

by Clinical Editor

No Comments

A schizophrenia drug candidate from partners Sumitomo Pharma and Otsuka Pharmaceutical failed to outperform a placebo in two Phase 3 studies. The compound is the most advanced program from psychiatry...

Aug 03 2023

Uncategorized

Phase III Flop in Schizophrenia; Top Psych Hospitals; Doubts on Cannabis Addiction

by Clinical Editor

No Comments

Trauma-focused, internet-delivered cognitive therapy was superior to a non-trauma-focused cognitive behavioral stress management therapy for reducing post-traumatic stress disorder (PTSD) symptoms in …

Aug 03 2023

Uncategorized

Detecting Schizophrenia Risk Early Via Brain Pattern Changes Linked to Age

by Clinical Editor

No Comments

A new study discovered age-related changes in brain patterns associated with the risk for developing schizophrenia.

Aug 03 2023

Uncategorized

New neuroimaging approach could improve diagnosis of schizophrenia

by Clinical Editor

No Comments

New research has identified age-related changes in brain patterns associated with the risk for developing schizophrenia. The discovery could help clinicians identify the risk for developing mental illness earlier and...

Aug 02 2023

Uncategorized

‘We have hope for some breakthroughs’: can we change the way we treat schizophrenia?

by Clinical Editor

No Comments

Scientists are cautiously optimistic that new approaches to treating the disabling condition may improve the lives of those affected by it …

Aug 02 2023

Uncategorized

Atopic dermatitis associated with schizophrenia, schizoaffective disorder

by Clinical Editor

No Comments

Atopic dermatitis (AD) is a chronic, inflammatory skin disorder that has well-established associations with depression and anxiety. A new Yale School of Medicine study, published in Archives of …

Aug 02 2023

Uncategorized

Sumitomo Schizophrenia Drug Discovered With AI Tech Fails in Two Phase 3 Trials

by Clinical Editor

No Comments

A schizophrenia drug candidate from partners Sumitomo Pharma and Otsuka Pharmaceutical failed to outperform a placebo in two Phase 3 studies. The compound is the most advanced program from psychiatry...

Aug 02 2023

Uncategorized

What to know about life expectancy for people with schizophrenia

by Clinical Editor

No Comments

Studies suggest that, on average, people with schizophrenia live around 10–20 years less than people without the condition, but this will depend on the individual. In many cases, the factors...